Professional Development
Learning Objectives:
At the end of the session, participants will be able to:
- identify key recommendations from the 2022 CCS Peripheral Arterial Disease (PAD) guidelines on management of PAD, that they can apply to their patients with PAD (Professional)
- describe key evidence that supports risk factor modification and drug therapy for patients with PAD (Expert, Communicator, Scholar)
- recognize the efficacy and safety of antithrombotic therapy in patients with PAD (Expert, Communicator, Scholar)
- advise optimal lifestyle strategies for patients with PAD (Expert, Communicator, Scholar)
Panelists: Dr. Sonia Anand, Dr. Eric Kaplovitch, Dr. John Mancini, Dr. Hassan Mir, and Dr. Darryl Wan